Evaluation of the thousands of proteins that comprise the human proteome and their post-translational modifications (PTMs) provides critical insight into cellular physiology and disease mechanisms that cannot be fully inferred from genomic data alone. Mass spectrometry proteomics is an ideal approach for such studies.
However, interrogation of the human proteome has been precluded to date by the lack of robust bioanalytical systems that enable comprehensive measure of diverse proteins, PTMs, and protein variants in complex human biosamples, including blood, with high throughput.
In this webinar hosted by AAPS, we discuss next-generation bioanalytical systems for proteomics studies in humans. We focus on high throughput, ‘discovery’ mass spectrometry proteomics as an analytical solution that now enables accurate and robust measure of thousands of proteins across thousands of individuals. This approach provides highly accurate protein identification and PTM information at scale.
We specifically cover how discovery mass spectrometry proteomics:
You’ll learn how Sapient’s high throughput, mass spectrometry proteomics method is transforming the depth and efficiency at which we can measure the blood and tissue proteome to extract greater biological insight.
10421 Wateridge Circle, Suite 100
San Diego, CA 92121
discover@sapient.bio
858.290.7010
© 2024 Sapient Bioanalytics, LLC. All rights reserved.
SAPIENT, the SAPIENT Logo, ACCELERATE HUMAN DISCOVERY, and SPECIFICITY AT SCALE are trademarks of Sapient Bioanalytics, LLC